Literature cited
R. E. Nitz and R. K. Pötzsch, Arzneimittel-Forsch.,13, 243 (1963).
W. Lochner and H. Hirche, Arzneimittel-Forsch.,13, No. 4, 251 (1963).
H. J. Bretschneider, H. J. Eberlein, H. M. Kabus, et al., Arzneimittel-Forsch.,13, 255 (1963).
H. Gille and F. Rausch, Med. Welt.,17, 715 (1966).
W. D. Bussman and W. Lochner, Arzneimittel-Forsch.,16, 51 (1966).
E. Schraven and R. E. Nitz, Arzneimittel-Forsch.,18, 396 (1968).
I. K. Shkhvatsabaya, L. A. Myasnikov, R. I. Metelitsa, et al., Kardiologiya, No. 2, 66 (1969).
G. Friese and D. Eisenbarth, Med. Welt.,19, 1896 (1968).
J. H. Maassen, Med. Klin.,31, 1269.
H. Roskaum, G. J. Frölich, and H. Reindell, Arzneimittel-Forsch.,16, No. 7, 835 (1966).
I. I. Sivkov, V. G. Kukes, V. S. Chicherina, et al., in: Experimental and Clinical Pharmcotherapy [in Russian], Riga, No. 5, (1973), pp. 61–66.
A. I. Prorvich, in: Current Problems of Theoretical and Clinical Medicine [in Russian], Minsk (1973), pp. 259–261.
Author information
Authors and Affiliations
Additional information
Translated from Khimiko Farmatsevticheskii Zhurnal, Vol. 9, No. 11, pp. 57–58, November, 1975.
Rights and permissions
About this article
Cite this article
Vitolin', R.O., Kimenis, A.A. & Petersone, I.O. The coronary-dilating agent carbocromene. Pharm Chem J 9, 742–743 (1975). https://doi.org/10.1007/BF00773303
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00773303